[On modifications of bilirubinemia after administration of vitamin K during the first month of life].
D000933:Antifibrinolytic Agents; D004899:Erythroblastosis, Fetal / Q000628:therapy*; D006932:Hyperbilirubinemia; D009285:Naphthoquinones; D014812:Vitamin K / Q000628:therapy*
D000933:Antifibrinolytic Agents; D009285:Naphthoquinones; D014812:Vitamin K
ERYTHROBLASTOSIS, FETAL/therapy; VITAMIN K/therapy